home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Arcturus Therapeutics Holdings Inc (NQ:ARCT)

8.900 +0.050 (+0.56%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcturus Therapeutics Holdings Inc

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Why CSL Ltd Stock Could Be Worth a Look

December 03, 2022

FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.

Via MarketBeat

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗

November 10, 2022

Upgrades

Via Benzinga

Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress

November 09, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Why Arcturus Therapeutics Stock Is Skyrocketing Today ↗

November 02, 2022

Investors are applauding Arcturus' collaboration with CSL.

Via The Motley Fool

Where Arcturus Therapeutics Stands With Analysts ↗

November 02, 2022

Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Arcturus Therapeutics to Present at the Following Investor Conferences in November

November 07, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗

November 03, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.

Via Benzinga

Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines ↗

November 02, 2022

Via Benzinga

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗

November 03, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗

November 02, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.

Via Benzinga

BARDA Backs Arcturus' Influenza Vaccine Program ↗

September 01, 2022

Via Benzinga

Arcturus' COVID-19 Booster Shows Durability Against Omicron Variants ↗

August 18, 2022

Via Benzinga

Why Is Rogers Corporation (ROG) Stock Down 44% Today? ↗

November 02, 2022

Rogers Corporation (ROG) stock is falling hard on Wednesday following confirmation that DuPont (DD) no longer plans to acquire the company.

Via InvestorPlace

Why Is Benefitfocus (BNFT) Stock Up 48% Today? ↗

November 02, 2022

Benefitfocus (BNFT) stock is rocketing higher on Wednesday as investors react to a $570 million acquisition deal with Voya Financial (VOYA).

Via InvestorPlace

Why Is Arcturus Therapeutics (ARCT) Stock Up 30% Today? ↗

November 02, 2022

The run-up in ARCT stock is practically unstoppable as two science-focused firms collaborate to develop mRNA technology.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 ↗

November 02, 2022

Upgrades

Via Benzinga

4 Analysts Have This to Say About Arcturus Therapeutics ↗

August 10, 2022

Within the last quarter, Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings:

Via Benzinga

What 4 Analyst Ratings Have To Say About Arcturus Therapeutics ↗

November 02, 2022

Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 02, 2022

Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.

Via Benzinga

Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket ↗

November 02, 2022

Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 02, 2022

Good morning, trader! It's time to take a look at all of the latest news behind the biggest pre-market stock movers on Thursday!

Via InvestorPlace

Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 02, 2022

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines

November 01, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022

October 26, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Arcturus Therapeutics to Attend the Following Investor Conferences

September 27, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

7 Small-Cap Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later ↗

September 22, 2022

With the market taking a dip and possibly poised to incur more red ink, these are the small-cap stocks to buy that appeal to contrarians.

Via InvestorPlace

Arcturus Therapeutics to Attend the Following Investor Conferences

September 01, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of Self-amplifying mRNA Vaccine for Rapid Pandemic Influenza Response

August 31, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 Vaccine

August 18, 2022

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com